71,047views
00:00 / 00:00
Immune system
Sepsis
Neonatal sepsis
Abscesses
Type I hypersensitivity
Food allergy
Anaphylaxis
Asthma
Type II hypersensitivity
Immune thrombocytopenic purpura
Autoimmune hemolytic anemia
Hemolytic disease of the newborn
Goodpasture syndrome
Rheumatic heart disease
Myasthenia gravis
Graves disease
Pemphigus vulgaris
Type III hypersensitivity
Serum sickness
Systemic lupus erythematosus
Poststreptococcal glomerulonephritis
Type IV hypersensitivity
Graft-versus-host disease
Contact dermatitis
Transplant rejection
Graft-versus-host disease
Cytomegalovirus infection after transplant (NORD)
Post-transplant lymphoproliferative disorders (NORD)
X-linked agammaglobulinemia
Selective immunoglobulin A deficiency
Common variable immunodeficiency
IgG subclass deficiency
Hyperimmunoglobulin E syndrome
Isolated primary immunoglobulin M deficiency
Thymic aplasia
DiGeorge syndrome
Severe combined immunodeficiency
Adenosine deaminase deficiency
Ataxia-telangiectasia
Hyper IgM syndrome
Wiskott-Aldrich syndrome
Leukocyte adhesion deficiency
Chediak-Higashi syndrome
Chronic granulomatous disease
Complement deficiency
Hereditary angioedema
Asplenia
Thymoma
Ruptured spleen
Blood transfusion reactions and transplant rejection: Pathology review
Immunodeficiencies: T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Combined T-cell and B-cell disorders: Pathology review
Immunodeficiencies: Phagocyte and complement dysfunction: Pathology review
Hyper IgM syndrome
0 / 6 complete
0 / 1 complete
of complete
of complete
Laboratory value | Result |
Complete blood count | |
Hemoglobin | 12 g/dL |
Leukocyte count | 10,100 /mm3 |
Platelet count | 200,000/mm3 |
Immunoglobulins | |
IgG | 250 mg/dL |
IgA | 24 mg/dL |
IgM | 700 mg/dL |
IgE | undetectable |
CD4/CD8 ratio | 2 (normal, 1-4) |
2022
2021
2020
2019
2018
2017
2016
hyper-IgM syndrome and p. 115
hyper-IgM syndrome and p. 115
hyper-IgM syndrome p. 115
hyper-IgM syndrome p. 115
hyper-IgM syndrome p. 115
hyper-IgM syndrome p. 115
hyper-IgM syndrome p. 115
Jake Ryan
Tanner Marshall, MS
Hannah Goerner
Hyper IgM syndrome is a problem where B cells are unable to undergo antibody class-switching, meaning that they can produce IgM antibodies, or immunoglobulins, but struggle to produce other types of antibodies, and that leaves individuals at risk for certain infections.
Let’s take a look at how B cells end up secreting different types of antibodies. Each B cell is born in the bone marrow from a stem cell and develops its own B cell receptor, which sits on the cell surface. The B cell receptor consists of two parts - a protein called CD79 that communicates with the rest of the cell and a membrane bound IgM or IgD antibody that can bind to an antigen. An antigen is any substance recognized by that particular antibody.
Each antibody has two identical light chains and two identical heavy chains that combine into a Y shape. So this Y-shaped antibody’s got two arms with identical tips, which is called the variable region. This variable region contains an antigen binding domain that’s unique to that antibody.
Below the variable region, or toward the point where the arms meet, is the constant region where every member of an antibody class is identical – so all IgM antibodies have the same constant region, but IgM and IgA constant regions are different.
And there are five classes of antibodies in total: IgM, IgG, IgA, IgE, and IgD class antibodies. And each antibody class has a slightly different job. For example, IgMs are part of B cell receptors, and are the first free-floating antibodies produced in an immune response. They’re secreted as a pentamer, meaning there are five antibodies connected together, which provides many binding sites for grabbing antigens and taking them out of the blood. Each antibody has complement protein binding sites on the heavy chains, so these IgM pentamers are also great at activating complement proteins, which help destroy and remove pathogens.
Copyright © 2023 Elsevier, except certain content provided by third parties
Cookies are used by this site.
USMLE® is a joint program of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). COMLEX-USA® is a registered trademark of The National Board of Osteopathic Medical Examiners, Inc. NCLEX-RN® is a registered trademark of the National Council of State Boards of Nursing, Inc. Test names and other trademarks are the property of the respective trademark holders. None of the trademark holders are endorsed by nor affiliated with Osmosis or this website.